Neuroglee Therapeutics: Funding, Investors & Team (Oct 2026)
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
Neuroglee Therapeutics has raised $12.3M across 2 funding rounds on record, the most recent a Series A of $10.0M announced in Sep 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neuroglee Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
Neuroglee Therapeutics Funding Rounds
Neuroglee Therapeutics raised $2.3M in an undisclosed round announced in Dec 2020.
9 months later, a Series A of $10.0M was announced in Sep 2021.
Neuroglee Therapeutics Founders and Leadership Team
Contact details for the Neuroglee Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Neuroglee Therapeutics Funding Compared to Other Biotechnology Startups
Neuroglee Therapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neuroglee Therapeutics in Biotechnology and Singapore
Companies Similar to Neuroglee Therapeutics
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Neuroglee Therapeutics Funding FAQs
What does Neuroglee Therapeutics do?
Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.
How much funding has Neuroglee Therapeutics raised?
Neuroglee Therapeutics has raised $12.3M across 2 rounds on record. The most recent is a Series A of $10.0M announced in Sep 2021.
When did Neuroglee Therapeutics last raise funding?
Neuroglee Therapeutics' most recent funding round on record is a Series A of $10.0M, announced in Sep 2021.
Who is the CEO of Neuroglee Therapeutics?
Aniket Singh Rajput is listed as CEO at Neuroglee Therapeutics.
Where is Neuroglee Therapeutics headquartered?
Neuroglee Therapeutics is based in Singapore, Central Region, Singapore.
How many employees does Neuroglee Therapeutics have?
Neuroglee Therapeutics is in the 11-50 employee band.
How does Neuroglee Therapeutics' funding compare to other Biotechnology startups?
Neuroglee Therapeutics' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Neuroglee Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neuroglee Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.